| (210) | Number of the EPO application | 18775644 |
| (220) | Filing date of the EPO application | 2018.03.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 25/2024, 2024.06.19 |
| (110) | EPO patent number | 3603669 |
| (21) | Number of the application | e 2020 0157 |
| (71) | Name(s) of applicant(s), code of the country | Meiji Seika Pharma Co., Ltd., JP;
Dong-A Socio Holdings Co., Ltd., KR; |
| (72) | Name(s) of inventor(s), code of the country | KAYA Arpansiree, JP;
FUJITA Michinari, JP; |
| (73) | Name(s) of owner(s), code of the country | Meiji Seika Pharma Co., Ltd., JP;
Dong-A Socio Holdings Co., Ltd., KR; |
| (54) | Title of the invention | AQUEOUS FORMULATION, AQUEOUS FORMULATION IN INJECTOR, ANTIBODY PROTEIN DISAGGREGATING AGENT, AND ANTIBODY PROTEIN DISAGGREGATION METHOD |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); A61K 9/08 (2006.01.01); A61K 47/18 (2017.01.01); A61K 47/26 (2006.01.01); A61P 17/06 (2006.01.01); A61P 37/02 (2006.01.01) |
| (19) | Country | JP |
| (41) | Date of publication of the application | 2020.03.31 |
| (30) | Priority | 2017070844, 2017.03.31, JP |
| (86) | International application | PCT/JP2018/013559, 2018.03.30 |
| (87) | International publication | WO 2018/181876, 2018.10.04 |